Successful treatment of patent ductus arteriosus and severe pulmonary hypertension using sildenafil and beraprost sodium in two dogs

J Vet Med Sci. 2025 Jul 7;87(7):798-803. doi: 10.1292/jvms.25-0097. Epub 2025 May 26.

Abstract

Two dogs with patent ductus arteriosus and severe pulmonary hypertension were presented to our veterinary teaching hospital. In both dogs, sildenafil was initiated to treat pulmonary hypertension, and surgery was supposed to be scheduled after dose titration. Although no obvious improvement in pulmonary hypertension was observed, no dog had polycythaemia or an increased haematocrit level. The dogs underwent ductal occlusion, and treatment with beraprost sodium was subsequently initiated. Thereafter, severe pulmonary hypertension dramatically improved. No dog showed any clinical sign of right heart failure or adverse drug reaction postoperatively, thereby demonstrating the successful treatment of two dogs with patent ductus arteriosus and severe pulmonary hypertension, using sildenafil and beraprost sodium.

Keywords: bidirectional shunt; ductus arteriosus; ductus closure; polycythaemia; right heart failure.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Dog Diseases* / drug therapy
  • Dogs
  • Ductus Arteriosus, Patent* / complications
  • Ductus Arteriosus, Patent* / drug therapy
  • Ductus Arteriosus, Patent* / veterinary
  • Epoprostenol* / analogs & derivatives
  • Epoprostenol* / therapeutic use
  • Female
  • Hypertension, Pulmonary* / drug therapy
  • Hypertension, Pulmonary* / veterinary
  • Male
  • Sildenafil Citrate* / therapeutic use
  • Vasodilator Agents* / therapeutic use

Substances

  • Sildenafil Citrate
  • beraprost
  • Epoprostenol
  • Vasodilator Agents